Zhe Wang

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 28, 2023
PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis.

Zhe Wang, Ruolei Li, Niuniu Hou

Pageof 1

Frequent Collaborators